close

Agreements

1 229 230 231 232 233 249
Number of results: 4964

PDF print is not allowed for data more than 3000.Please search above for fewer data.

Date Company Compound Disease Type of agreement Therapeutic area Type of Information
2012-01-05 GSK (UK) ChemoCentryx (USA - CA) CCX354 rheumatoid arthritis Autoimmune diseases – Inflammatory diseases - Rheumatic diseases Exercise of an option agreement
2012-01-04 AM-Pharma (The Netherlands)

nomination

Inflammatory diseases Nomination
2011-12-22 Vivalis (France) undisclosed animal health company EB66® cell line for the production of several animal health vaccine licensing Veterinary medicine
2011-12-21 Arecor (UK) Eli Lilly (USA) stable aqueous or higher concentration formulations of emerging protein and peptide drug candidates developed by Lilly R&D
2011-12-20 Genmab (Denmark) - undisclosed pharma company DuoBody™ Platform

solid tumors

R&D Cancer Oncology
2011-12-20 Affibody (Sweden) Nuclisome (Sweden) new cancer therapeutics cancer R&D Cancer Oncology
2011-12-19 Summit (UK) Muscular Dystrophy Association (USA) Parent Project Muscular Dystrophy (USA) Charley’s Fund (USA) Cure Duchenne (USA) Foundation to Eradicate Duchenne (USA) Nash Avery Foundation (USA) SMT C1100 Duchenne muscular dystrophy Genetic diseases - Neuromuscular diseases - Rare diseases Establishment of a new subsidiary in the EU
2011-12-19 Amgen (USA - CA) Watson Pharmaceuticals (USA - NJ), now Actavis (Ireland), now Allergan (Ireland) oncology biosimilar products

development

commercialisation

Cancer - Oncology Development agreement
2011-12-16 Transgene (France) French League against Cancer (France) new anticancer biotherapies cancer

R&D

Cancer - Oncology R&D agreement
2011-12-16 Pharming (The Netherlands) Renova Life (USA) development and supply of founder transgenic rabbits hemophilia A

services

Hematological diseases - Genetic diseases - Rare diseases Services contract
2011-12-16 GSK (UK) GAVI Alliance pneumococcal vaccine, Synflorix® pneumococcal disease

supply

Infectious diseases Collaboration agreement
2011-12-15 Morphosys (Germany) Novozymes (Denmark) Slonomics technology

licensing
technology transfert

Licensing agreement
2011-12-15 GSK (UK) The University of Dundee (UK) Huntington’s disease

R&D

Rare diseases - Genetic diseases - Neurodegenerative diseases R&D agreement
2011-12-15 Shire (UK-USA) Atlas Venture (USA)

collaboration

Rare diseases Collaboration agreement
2011-12-13 Biotie Therapies (Finland) National Institute on Drug Abuse (NIDA-USA) nepicastat (SYN117) cocaine dependence clinical research CNS diseases - Mental diseases Clinical research agreement
2011-12-13 Prestwick Chemical (France) Pharma Plexus Holland (The Netherlands) lead optimization services

collaboration

Collaboration agreement
2011-12-13 Camurus (Sweden) Novartis (Switzerland) octreotide product CAM2029 and the FluidCrystal® Injection depot technology

collaboration
option
licensing

Licensing agreement
2011-12-13 Polytherics (UK) Nuron Biotech (USA) PolyTherics’ TheraPEG™ conjugation technology

licensing

Licensing agreement
2011-12-13 BiolineRx (Israel) Compugen (Israel) Compugen-discovered drug candidates including the three peptides CGEN-855, CGEN-856 (now BL-7060) and CGEN-25017 (now BL-8010)

collaboration
development
commercialisation

Inflammatory diseases - Cardiovascular diseases - Cancer - Oncology Collaboration agreement
2011-12-09 Dako (Denmark) Genentech a member of the Roche Group (USA-Switzerland) HercepTest® and HER2 FISH pharmDx® as companion diagnostics for pertuzumab advanced HER2-positive breast cancer

collaboration

Cancer Oncology Collaboration agreement